TCM Cohort for Elderly COPD
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorHenan University of Traditional Chinese Medicine
About this trial
This study evaluates the real-world clinical efficacy of traditional Chinese medicine (TCM) in elderly Chronic obstructive pulmonary disease (COPD) patients and explores syndrome characteristics and their associations with biomarkers.
Eligibility criteria
Qualifiers
Patients diagnosed with COPD;
Age ≥ 60 years old;
Voluntary participation in this study, and sign the informed consent form.
Disqualifiers
Patients with various mental illnesses or other conditions that prevent normal communication;
Patients with a history of pulmonary surgery, such as lung volume reduction surgery or lung transplantation;
Patients with confirmed human immunodeficiency virus infection or acquired immunodeficiency syndrome.
Trial design
Treatments tested in this trial
- Traditional Chinese medicine (TCM)
- Non-traditional Chinese medicine (non-TCM)
Treatment groups
2,386 Participants
are divided into 2 treatment groupsSponsors and collaborators
Henan University of Traditional Chinese Medicine
Lead sponsor
The First Affiliated Hospital of Henan University of Chinese Medicine
Collaborator
The First Affiliated Hospital of Guangzhou Medical University
Collaborator
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Collaborator
Source ClinicalTrials.gov